Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanjivani Paranteral Limited has issued a Postal Ballot Notice seeking shareholder approval to regularise the appointment of Mr. Basant Shrivastava (DIN: 02581255) as a Non-Executive Independent Director. Mr. Shrivastava, aged 69, was initially appointed as an Additional Director by the Board on 11th September 2025, on the recommendation of the Nomination and Remuneration Committee. The resolution seeks his appointment as Independent Director for a 5-year term up to 10th September 2030, and he is not liable to retire by rotation. The e-voting period runs from 5th November 2025 (9:00 AM) to 4th December 2025 (5:00 PM), with results to be declared on or before 6th December 2025. Mr. Shrivastava holds an MBA from JBIMS and an M.Sc. in Chemistry, with over 40 years of pharmaceutical sales and marketing experience across Johnson & Johnson, Vita Pharma, and currently Joint Force Pharma Ltd.
This is a routine regulatory requirement to regularise an independent director appointment made earlier in September 2025. Shareholders should vote on the resolution during the e-voting window. The appointment itself is not expected to materially impact stock price or business operations, but approval is necessary for SEBI Listing Regulation compliance.